Developer of novel cancer treatments designed to target the deoxyribonucleic acid (DNA) damage response. The company's treatments focus on developing therapies through deoxyribonucleic acid damage res...

Healthcare
Cambridge, United Kingdom
Founded 2015
121 employees
Website
Valuation
$0
Share Price
N/A
Total Raised
$385.1M
Last Round
N/A